{
    "children": {
        "NCT03254875": {
            "children": {},
            "data": {
                "Acronym": "REBECCA II",
                "Age": "18 Years and older   (Adult, Older Adult)",
                "Completion Date": "May 31, 2021",
                "Conditions": "Breast Cancer",
                "Enrollment": "324",
                "First Posted": "August 21, 2017",
                "Funded Bys": "Other",
                "Gender": "Female",
                "Interventions": "Behavioral: Individually tailored nurse navigation",
                "Last Update Posted": "May 6, 2020",
                "Locations": "Rigshospitalet, Copenhagen, Denmark",
                "NCT Number": "NCT03254875",
                "Other IDs": "REBECCA II",
                "Outcome Measures": "Distress|Depression|Anxiety|Health related quality of life summary index|Breast cancer related quality of life summary index|Functional related quality of life summary index|Physical health related quality of life|Social health related quality of life|Emotional health related quality of life|Self-efficacy|Fear of recurrence|Pain in the breast surgery area (side of chest, armpit or arm)|Neuropathy in the breast surgery area (side of chest, armpit or arm)|Sleep quality|Cognitive function - Perceived cognitive impairments|Cognitive function- Perceived cognitive impairments|Cognitive function - Impact of Perceived cognitive impairments on quality of life|Cognitive function - Perceived cognitive abilities|Need for support|Health care costs|Acceptability",
                "Phases": "Not Applicable",
                "Primary Completion Date": "May 31, 2021",
                "Rank": "1",
                "Results First Posted": "",
                "Sponsor/Collaborators": "Danish Cancer Society|Rigshospitalet, Denmark|Copenhagen University Hospital at Herlev",
                "Start Date": "August 15, 2017",
                "Status": "Active, not recruiting",
                "Study Designs": "Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care",
                "Study Documents": "",
                "Study Results": "No Results Available",
                "Study Type": "Interventional",
                "Title": "Rehabilitation After Breast Cancer",
                "URL": "https://ClinicalTrials.gov/show/NCT03254875"
            },
            "inclusion_criteria": [
                {
                    "text": "Text1",
                    "hinting": ""
                },
                {
                    "text": "Text2",
                    "hinting": ""
                }
            ],
            "exclusion_criteria": []
        },
        "NCT03721211": {
            "children": {},
            "data": {
                "Acronym": "",
                "Age": "18 Years and older   (Adult, Older Adult)",
                "Completion Date": "October 31, 2024",
                "Conditions": "Breast Cancer",
                "Enrollment": "0",
                "First Posted": "October 26, 2018",
                "Funded Bys": "Other",
                "Gender": "Female",
                "Interventions": "Drug: [11C]Martinostat|Device: MR-PET scanner",
                "Last Update Posted": "March 3, 2020",
                "Locations": "Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States",
                "NCT Number": "NCT03721211",
                "Other IDs": "17-447",
                "Outcome Measures": "PET-MRI Visualization and Quantification of Breast Tumor Uptake of [11C]Martinostat Above Background Uptake, as Assessed by SUV Measurements|Quantitative [11C]Martinostat-PET Uptake in Primary Breast Cancer, and Correlation with Expression of HDAC Isoforms|Correlation of Total Volume of Distribution of Dynamic [11C]Martinostat Uptake with Expression of HDAC Isoforms|Comparison of HDAC Isoform Expression by Western Blot Across Breast Tumor Subtypes|HDAC Expression Levels in Breast Tumors Compared to HDAC Expression in Adjacent Normal Breast Parenchyma",
                "Phases": "Phase 1",
                "Primary Completion Date": "February 28, 2020",
                "Rank": "2",
                "Results First Posted": "",
                "Sponsor/Collaborators": "Christine Elizabeth Edmonds|Massachusetts General Hospital",
                "Start Date": "February 1, 2020",
                "Status": "Withdrawn",
                "Study Designs": "Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic",
                "Study Documents": "",
                "Study Results": "No Results Available",
                "Study Type": "Interventional",
                "Title": "Imaging With [11C]Martinostat in Breast Cancer",
                "URL": "https://ClinicalTrials.gov/show/NCT03721211"
            },
            "inclusion_criteria": [
                {
                    "text": "Text1",
                    "hinting": ""
                },
                {
                    "text": "Text2",
                    "hinting": ""
                }
            ],
            "exclusion_criteria": []
        }
    },
    "data": {},
    "inclusion_criteria": [],
    "exclusion_criteria": []
}